Overexpressions of FGFR4 and β-klotho in the liver of FGF21KO-HFMCD mice with advanced NASH were confirmed by IHC and qPCR (Figure S3). Here, FGFR4 is linked to metabolic dysfunction-associated steatohepatitis.